IBM Clinical Trial Management System (CTMS) for Sites, formally known as Merge Clinical Trial Management System for Investigators, is a platform used by institutions conducting research to organize, centralize, and manage clinical research operations and finances across their institution. It supports large hospitals and academic organizations as well as independent research organizations. When implemented as part of the central research infrastructure at clinical research sites, CTMS for Sites helps to streamline the clinical trial process and maximizes operational efficiencies. It is designed to reduce financial compliance risk, increase performance transparency across organizations, maximize revenue or cost coverage, reduce burden of duplicate data entry, and support efficient participant recruitment. CTMS for Sites provides a building block for centralization and standardization at research sites and can help create an end-to-end ecosystem that supports clinical care as well as research, regardless of research specialty or site type.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries. Learn more at www.iqvia.com.
Veeva is the global leader in cloud software for the life sciences industry, serving more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging sites. As a Public Benefit Corporation, Veeva is committed to balancing the interests of its customers, employees, shareholders, and the industries it serves. Learn more at veeva.com.
Veeva SiteVault is the only unified solution connecting sites with sponsors and patients to run digital trials. Streamline regulatory processes and connect to 400+ sponsors that use Veeva Clinical applications. Learn more at sites.veeva.com.
CLiX AI automates the interrogation and structure of patient’s narrative data to give CROs and Sponsors a distinct data-driven advantage at critical points throughout the clinical trial life cycle. With the CLiX accelerate solution it is possible to:
• Increase predictability and reduce risk during bid phase feasibility assessment
• Shorten study start-up time by speeding up subject recruitment
• Automate retrospective information sorting for more accurate risk evaluation and mitigation during post-market surveillance
Ok, that’s about it!
An SCRS Global Impact Partner™
With more than 1,500,000 registered healthcare professionals worldwide, growing at an average of 15,000 – 22,500 new registrants per month, BlueCloud® has the fastest growing networks in healthcare and clinical research. A global networking technology that enables industry stakeholders to create new and efficient business models that improve patient care by implementing standards and eliminating waste and fraud. This ecosystem allows the exchange of “real-time” information required by regulatory agencies. BlueCloud acts as the catalyst for standardizing global programs like the NIH Stroke Scale (NIHSS), Modified Rankin mRS, Barthel Index (BI), Suicidality Scale (C-SSRS) and other diagnostic neuroscience programs. Let’s save lives, together!”.
For more information visit www.healthcarepoint.com
Revolutionizing Clinical Trials
Founded in 2007, Clinical Ink is the pioneering provider of eSource solutions for clinical trials. Developers of SureSource® — the first purpose-built and most widely used eSource plaftform — Clinical Ink is dedicated to streamlining clinical development from Start to Submit™.
Ideal for every phase of clinical development, SureSource makes clinical research easier for sites, sponsors, subjects and regulators. As the only purpose-built solution that meets all regulatory requirements for eSource, SureSource was developed from the beginning to streamline clinical research — by experts in the fields of clinical investigations and medical forms publishing.
Discover how Clinical Ink’s SureSource platform can speed data access to dramatically reduce clinical trial costs and timelines.
